FTC’s PBM Suit: A Stopped Clock is Right Twice a Day

A recent Wall Street Journal editorial, “The FTC’s Anti-PBM Suit Could Mean Higher Health Premiums,” misses the mark on Pharmacy Benefit Managers (PBM). We respectfully disagree.

For the past three years, the Biden-Harris Federal Trade Commission (FTC) under Chair Lina Khan has engaged in fiercely ideological efforts that harm consumers more than they help.

But as the adage goes, even a stopped clock is right twice a day. The FTC’s investigation and subsequent lawsuit regarding pharmacy benefit manager (PBM) practices would help restore a degree of desperately needed competition to our healthcare system.

Read the full piece >